EMSLX
Price
$16.84
Change
+$0.24 (+1.45%)
Updated
Apr 23 closing price
Net Assets
22.17M
VEMRX
Price
$93.66
Change
+$1.10 (+1.19%)
Updated
Apr 23 closing price
Net Assets
111.75B
Ad is loading...

EMSLX vs VEMRX

Header iconEMSLX vs VEMRX Comparison
Open Charts EMSLX vs VEMRXBanner chart's image
Shelton Emerging Markets Investor
Price$16.84
Change+$0.24 (+1.45%)
VolumeN/A
Net Assets22.17M
Vanguard Emerging Mkts Stock Idx InsPlus
Price$93.66
Change+$1.10 (+1.19%)
VolumeN/A
Net Assets111.75B
EMSLX vs VEMRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
EMSLX vs. VEMRX commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EMSLX is a Buy and VEMRX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEMRX has more cash in the bank: 112B vs. EMSLX (22.2M). EMSLX pays higher dividends than VEMRX: EMSLX (3.90) vs VEMRX (3.14). EMSLX was incepted earlier than VEMRX: EMSLX (19 years) vs VEMRX (14 years). EMSLX (1.94) is less costly to investors than VEMRX (0.07). EMSLX is a more actively managed with annual turnover of: 63.00 vs. VEMRX (8.00). EMSLX has a lower initial minimum investment than VEMRX: EMSLX (1000) vs VEMRX (100000000). VEMRX annual gain was more profitable for investors over the last year : 8.18 vs. EMSLX (1.83). EMSLX return over 5 years is better than : 50.75 vs. VEMRX (38.21).
EMSLXVEMRXEMSLX / VEMRX
Total Expense Ratio1.230.071,757%
Annual Report Gross Expense Ratio1.940.072,771%
Fund Existence19 years14 years-
Gain YTD0.181-0.403-45%
Front LoadN/AN/A-
Min. Initial Investment10001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets22.2M112B0%
Annual Yield % from dividends3.903.14124%
Returns for 1 year1.838.1822%
Returns for 3 years-1.038.51-12%
Returns for 5 years50.7538.21133%
Returns for 10 years26.6117.69150%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SLRX0.720.06
+9.26%
Salarius Pharmaceuticals Inc.
MTZ118.414.16
+3.64%
MasTec
CCB88.671.79
+2.06%
Coastal Financial Corp
BHVN21.420.27
+1.28%
Biohaven Ltd
XBIT3.150.03
+0.96%
XBiotech